G-protein-coupled estrogen receptor GPER-1 expression in hormone receptor-positive breast cancer is associated with poor benefit of tamoxifen.

Tanja IgnatovMaria ClausNorbert NassJohannes HaybaeckBernd SeifertThomas KalinskiOlaf OrtmannAtanas Ignatov

Published in: Breast cancer research and treatment (2018)

GPER-1 expression is a favorable prognostic factor in breast cancer patients. Its predictive role for poor benefit form tamoxifen treatment should be investigated in further studies.

Keyphrases

estrogen receptor
positive breast cancer
prognostic factors
poor prognosis
binding protein
long non coding rna
mass spectrometry
atomic force microscopy
combination therapy
replacement therapy